CDI-31244

· Cocrystal Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CDI-31244, covering 2021-04-28 to 2021-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL) [Phase 2]